Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Cathy wood is too ahead of market and sometimes it becomes problem because short term, it might drop so much because of economic conditions.
1)Agriculture,2)Industrial, 3)Computer, 4)Internet, 5)finally, AI
Every time something gets revolutionized everything gets more efficient and creates better circumstances in humanity. AI is the smartest invention of human beings because AI will create even better things than human did.
NVDA is huge part of it snd without their products, AI won’t exist. AI is way underestimated at this point or people have not figured out the potential yet.
Oh, I see. Great. That is smart way to protect. I appreciate you correcting me. Now, I am more comfortable holding SI!
I hold SI, too, but By the way, George Soros is Short Silvergate.
Depends on what stocks you hold.
Yes, matter of time. All the frenzy FTX created or by other exchanges will dust away and SI should do well, but do exchange have to use Silvergate capital bank for crypto? That is the question.
As long as crypto stay here or goes up and market is positive and keep the bill market trend, SI should clime up higher, IMP. Short interest is 63% or so, too. It is all depends on market how SI will play out.
Oh, I heard on CNBC just now BINANCE moved $400M from Silvergate crypto bank without them knowing. It seemed impacted investors sell off SI stock.
Market in general got negative sentiment. PPI # was high, one of the FED person said rate will go up much higher, market got pessimistic, not directly SI stock, it might have something to do with chart, too ??IMO. Stocks never go straight up.
I want to see them add whole s lot, not only $100k or $200k. They have about 7M shares now.
This is my long term or it goes to $0 and lose it all.
Yes, give it a shot!
Everyone got out of this already? ONVO had a good day today!
It is showing some life here today. 10Q is out. I believe that is the reason.
If anyone like action, Check out BZFD! I think it will go crazy and huge dump coming later!
More coming and If anyone like action, Check out BZFD! I think it will go crazy and huge dump coming later!
HOLO is amazing, but go up too fast and I can not trust this company activity. I moved 75% of money I made to WIMI which has more legit informations.
Wait, is this ganna create sell off tomorrow?
4:19
News Detail
TI
Madrigal Pharmaceuticals raised $239 ml in gross equity from equity securities issuances and additional $50 mln in liquidity commitments
4:18 PM ET 12/21/2022 | Briefing.com
MDGL
Co announces that it has raised $259 million in gross equity (or $255 million in net proceeds) from equity securities issuances and an additional $50 million in liquidity commitments following the achievement of the clinical milestone under its Hercules Credit
Facility.Madrigal has completed $159 million in gross sales of common stock under its ATM Program ("ATM
Sales") and has separately entered into a $100 million definitive securities purchase agreement with two of its existing institutional investors for the purchase of $90 million in shares of Series B Convertible Preferred
Stock (the "Series B") and $10 million in shares of the Company's common stock.In connection with Madrigal's December 19, 2022 announcement of positive topline data from its pivotal Phase 3
MAESTRO-NASH clinical trial of resmetirom, Hercules Capital, Inc. (HTGC) confirmed that Madrigal has achieved its clinical milestone under the Company's Credit Facility with Hercules, thereby enabling Madrigal to draw upon a $50 million clinical milestone tranche over the next three months.
Oh, well
There are no set rules regarding how long a short sale can last before being closed out. The lender of the shorted shares can request that the shares be returned by the investor at any time, with minimal notice, but this rarely happens in practice so long as the short seller keeps paying their margin interest.
Shorting stocks should be more strict than this….
I am sure a lot of traders are shorting MDGL already. How soon do they have to cover the short? Do you know?
MDGL might be holding well because smart investors know FDA approval is imminent or merger and buyout. I am expecting much higher price or the deal.
That is good sign, no pump and dump?
I can not find any article or info from 9/30 presentations….
-10/5/22 they held 1.416M shares at around $9 per share.
-They start unload since 1/6/21-3/30/21 for 929,307 shares.
-during that time it hit as high as $23 per share.
-after that, they are keeping unloading a little by little.
-as of 9/30/22, they still hold 271,860 shares.
-I wish I could send picture of what they did.
*IMO, they will keep unloading slowly and most likely, they will sell everything. ONVO was high risk, high return. Now IT IS “HIGHER RISK, HIGHER RETURN.” My wife needs liver transplant, I am hoping this company to do well, so whether risky or not, I bought some and holding. I am praying.
Thank you for asking, “UP 140%!”
But because I bought at $0.65, expiring Oct. 21 $2.50 call before the drop, I am still down more than 30%, haha, but I am happy to see TCRT going back up!
Let’s gooooo!
Did any company make SGFY deal already? Cathie is almost done selling, I don’t know who else has a lot of shares to sell to bring this down.
One question if you know…
Why do you think Cathie buys VLD and MFKG very small amount everyday?
Ouch, I got killed today. I bought option call and the value became only half now…
Good luck everyone. I am still hoping for good presentation on 9/30/22. This needs to turn around.
I hope the presentation to be amazing on 9/30/22.
My friend found this yesterday
CRT's stock is down on heavy volume as a blog post from the husband of treated
Patient #2 reported that she has stopped therapy due to a mutation
(https://www.givesendgo.com/Woldt). While social media post are not company
press releases and in the vast majority of situations must be taken with a grain of
salt, there appears to be some validity here. With data from the objective response
(OR) seen in Patient #1 - who has lung cancer - about to be presented on
September 30, we are buyers of TCRT here on weakness. BUY.
Details from GoFundMe Blog
Now all of this from the unsolicited blog/link above. The woman has advanced
colon cancer which was targeted with P53 mutation from the TCR-T Library. She
started treatment late-Spring/early Summer that initially resulted in a 27% tumor
reduction. The mutation appears to have occurred after recent blood work was
performed at MD Andersen. A mutation in colon cancer is not unheard of as colon
cancer is known to often mutate when under pressure, i.e. chemotherapy.
Importantly and despite the setback in treatment, the patient is healthy enough to
resume chemotherapy and did not appear to suffer any platform-related side
effects that might have a negative read through to TCRT. Hence is the beauty of
the Alaunos' Sleeping Beauty kill switch and stopping the overactive immune
response before it gets out of control. As a reminder, all of this is unconfirmed
although the blog and its details appear legit.
Patient #1 Is Key
Most importantly, Alaunos recently confirmed that it has seen an objective partial
response (OR) in the first patient treated in the study. Patient #1 has non-small c
lung cancer, and had one prior line of adjuvant therapy following surgery and thre
prior lines of systemic therapy. The patient has a tumor with a KRAS G12D
mutation, not P53. The patient was treated at the first dose level with TCR-T cells.
an objective response was observed and has now cleared the 28-day safety
window. TCRT will report initial data from the study on Friday, September 30,
8:30am ET at the CRI-ENCI-AACR Sixth International Cancer Immunotherapy
Conference.
A LOT MORE TO COME
In our view, the TCR-T platform has the ability to treat solid tumors with CAR-T
therapy, and the setback with Patient #2 will be a learning event for the Company.
The proprietary safety kill switch is a life saver in immuno-oncology. With only two
very late-stage patients having been treated, a 50% overall response rate (ORR)
would be more than acceptable.
The Company is advancing it's TCR-T Library Phase 1/2 trial targeting KRAS,
TP53 and EGFR mutations across six solid tumor indications, obviously the first
being lung, the second colorectal. We expect the upcoming detailed data from
Patient #1 will be positive and help the stock to regain its momentum. As we know
that different tumors respond differently and this is a very small sample size we are
dealing with; hence, the wild volatility in TCRT shares. However, we know for sure
that the platform has resulted in at least one objective response in a very advanced
lung cancer patient at the first dose, and that patient has been cleared by the FDA
to advance to the next dose. We are buyers on this weakness.
Coming back down now. I hope my feeling or intuition is right. Good luck to you.
Yeah, need to check broker bid/ask. I tried to catch falling knife and I caught it. I hope I don’t cut my hands badly. I usually cut my hands really deep, haha.
They lost(-$0.25) last 12 month. That is why. I see to take advantage of this is great idea at $1.30. If much higher price, I am not sure short term.
No, I put limit order at $1.30, luckily it got filled. It went down as low as $1.26. I was thinking to sell, but I decide to keep to see what is coming in the future. I like to take chance.
I saw that and it is not halted anymore, so I added my position at $1.30. If the final stage results are good and approved, TRCT lost $0.25 last 12 month should be nothing, but just buying opportunity here. Future should be bright. We will see.
…
TCRT lost -$0.25 last 12 month. Time to buy more.
What did just happen ? Down 33%?
Cathie wood keeps buying this slowly for a while. VLD might make future millionaires, potential is crazy and no one really does not know the potential of technology yet. It is still developing stage.
Elon wanted to buy out this company like 2 years ago, I heard.
This is June, so this is old news?